Skip to main content

Peer Review reports

From: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial

Original Submission
26 Nov 2020 Submitted Original manuscript
30 Oct 2021 Reviewed Reviewer Report - Gillian Gresham
29 Nov 2021 Author responded Author comments - Christopher Kai-shun Leung
Resubmission - Version 2
29 Nov 2021 Submitted Manuscript version 2
5 Dec 2021 Reviewed Reviewer Report - Gillian Gresham
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
23 Dec 2021 Editorially accepted
17 Jan 2022 Article published 10.1186/s13063-021-05968-1

You can find further information about peer review here.

Back to article page